Silymarin Ameliorates Diabetes-Induced Proangiogenic Response in Brain Endothelial Cells through a GSK-3β Inhibition-Induced Reduction of VEGF Release.
about
Silymarin Ameliorates Diabetes-Induced Proangiogenic Response in Brain Endothelial Cells through a GSK-3β Inhibition-Induced Reduction of VEGF Release.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Silymarin Ameliorates Diabetes ...... ced Reduction of VEGF Release.
@en
Silymarin Ameliorates Diabetes ...... ced Reduction of VEGF Release.
@nl
type
label
Silymarin Ameliorates Diabetes ...... ced Reduction of VEGF Release.
@en
Silymarin Ameliorates Diabetes ...... ced Reduction of VEGF Release.
@nl
prefLabel
Silymarin Ameliorates Diabetes ...... ced Reduction of VEGF Release.
@en
Silymarin Ameliorates Diabetes ...... ced Reduction of VEGF Release.
@nl
P2860
P356
P1476
Silymarin Ameliorates Diabetes ...... ced Reduction of VEGF Release.
@en
P2093
Enaam Alkhazaleh
Tamam El-Elimat
P2860
P304
P356
10.1155/2017/2537216
P577
2017-10-25T00:00:00Z